A Review of Daclatasvir Drug–Drug Interactions

The treatment of hepatitis C virus (HCV) infection has been revolutionized in recent years by the development of direct-acting antiviral regimens that do not contain peginterferon (pegIFN) and/or ribavirin (RBV). While direct-acting antiviral-based regimens have been shown to be greatly superior to...

Descripción completa

Detalles Bibliográficos
Autores principales: Garimella, Tushar, You, Xiaoli, Wang, Reena, Huang, Shu-Pang, Kandoussi, Hamza, Bifano, Marc, Bertz, Richard, Eley, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083780/
https://www.ncbi.nlm.nih.gov/pubmed/27664109
http://dx.doi.org/10.1007/s12325-016-0407-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083780/
https://www.ncbi.nlm.nih.gov/pubmed/27664109
http://dx.doi.org/10.1007/s12325-016-0407-5

Ejemplares similares